Isolated Late Metastasis of a Renal Cell Cancer Treated by Radical Distal Pancreatectomy

por Barras, J. P., Baer, H., Stenzl, A., Czerniak, A.
Publicado 1996

Cost Effective Laparoendoscopic Single-Site Surgery with a Reusable Platform

por Schwentner, C., Todenhöfer, T., Seibold, J., Alloussi, S., Aufderklamm, S., Mischinger, J., Stenzl, A., Gakis, G.
Publicado 2013

Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.

por Eder, I. E., Stenzl, A., Hobisch, A., Cronauer, M. V., Bartsch, G., Klocker, H.
Publicado 1997

A high-fidelity prototype of a sterile information system for the perioperative area: OR-Pad

por Ryniak, C., Frommer, S. M., Junger, D., Lohmann, S., Stadelmaier, M., Schmutz, P., Stenzl, A., Hirt, B., Burgert, O.
Publicado 2022

Economic aspects of bladder cancer: what are the benefits and costs?

por Sievert, K. D., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., Hennenlotter, J., Kruck, S., Stenzl, A.
Publicado 2009

Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical steps

por Sim, A., Todenhöfer, T., Mischinger, J., Fahmy, O., Boettge, J., Rausch, S., Bier, S., Aufderklamm, S., Stenzl, A., Gakis, G., Schwentner, C.
Publicado 2016

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma

por Aicher, Wilhelm K., Korn, M., Reitnauer, L., Maurer, F. B., Hennenlotter, J., Black, P. C., Todenhofer, T., Bedke, J., Stenzl, A.
Publicado 2021

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma

por Gebauer, K, Peters, I, Dubrowinskaja, N, Hennenlotter, J, Abbas, M, Scherer, R, Tezval, H, Merseburger, A S, Stenzl, A, Kuczyk, M A, Serth, J
Publicado 2013

COVID-19 in der europäischen Urologie: Was haben wir bisher gelernt?

por Rassweiler, J. J., Pini, G., Liatsikos, F., Georgiev, M., Roupret, M., Breda, A., Knoll, T., Micali, S., Stenzl, A., Goezen, A. S., Yanev, K., Rassweiler-Seyfried, M.-C.
Publicado 2021

The HELENA study: Hexvix(®)-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy—a prospective randomized controlled open-label multicenter non-inferiority stud...

por Gierth, M., Breyer, J., Zeman, F., Fritsche, H. M., Cordes, J., Karl, A., Zaak, D., Stenzl, A., von Schmeling, I. Kausch, Sommerhuber, A., Zierer, T., Burger, M., Mayr, R.
Publicado 2021

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

por Vogelhuber, M., Feyerabend, S., Stenzl, A., Suedhoff, T., Schulze, M., Huebner, J., Oberneder, R., Wieland, W., Mueller, S., Eichhorn, F., Heinzer, H., Schmidt, K., Baier, M., Ruebel, A., Birkholz, K., Bakhshandeh-Bath, A., Andreesen, R., Herr, W., Reichle, A.
Publicado 2014